Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study
Crossref DOI link: https://doi.org/10.1007/s11255-014-0800-4
Published Online: 2014-08-14
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cases, Aleix
Portolés, José
Calls, Jordi
Martinez-Castelao, Alberto
Munar, María Antonia
Segarra, Alfonso
Text and Data Mining valid from 2014-08-14